Akili digital therapeutic shows promise in lupus patients
Akili looks like it could bring another digital therapeutic (DTx) to market after a clinical trial backed the efficacy of its AKL-T01 in patients with […]
Akili looks like it could bring another digital therapeutic (DTx) to market after a clinical trial backed the efficacy of its AKL-T01 in patients with […]
Digital health company Akili Interactive has agreed a deal that could see its gamified therapy for attention-deficit hyperactivity disorder (ADHD) hosted on the creative gaming […]
Gaming industry veteran Jon David, responsible for highly-downloaded mobile games, including the Bejeweled and Plants vs Zombies franchises, has moved into the digital health arena […]
Akili Interactive’s prescription gaming app for attention deficit hyperactivity disorder (ADHD) EndeavorRx has been show to enhance neuronal activity in an area of the brain […]
Akili Interactive has agreed a merger with special purpose acquisition company (SPAC) Social Capital Suvretta Holdings Corp I in a deal that will take it […]
The company is licensing out technology from Australian digital health company TALi Digital to improve attention in early childhood. Akili will pay $37.5 million, including […]
Digital health player Akili has raised $110 million fourth-round funding, backed by a number of pharma groups, as it works towards extending its product range […]
A digital tool used to treat attention-deficit hyperactivity disorder (ADHD) is being tested to see if it can help counter lingering, fuzzy thinking in COVID-19 […]
Akili Interactive received FDA clearance last year for its game-based digital therapeutic to be used as a treatment for ADHD. Now, the company is testing […]
Akili has published data backing the efficacy of its childhood attention-deficit hyperactivity disorder (ADHD) video game therapy EndeavorRx in the peer-review journal Nature Digital Medicine. […]
Copyright © 2024 | WordPress Theme by MH Themes